NORRIS CHARLES A
Known title: DirectorCIK: 0001230730
NORRIS CHARLES A's purchase track record
NORRIS CHARLES A has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/29/2021 | FRPT | $550K | -12.4% | -33.8% | -11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| FRPT | ▲ Buy | Grant | 2,994 | $0 | 3/13/2023 | View on chart |
| FRPT | ▲ Buy | Grant | 2,015 | $0 | 3/14/2022 | View on chart |
| FRPT | ▲ Buy | Open Market | 5,000 | $550K | 11/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Freshpet Q2 Earnings Call Held; Wells Fargo Lowers Price Target
Freshpet held its Q2 2026 earnings call, a key event for investors tracking the pet food maker. Following the release, Wells Fargo maintained an Overweight rating but lowered its price target to $77. This adjustment places the bank's view below the current average analyst target of $84.25, reflecting a more cautious outlook on the stock's valuation.
Freshpet Q2 Earnings Call Held; Wells Fargo Lowers Price Target. Freshpet held its Q2 2026 earnings call, a key event for investors tracking the pet food maker. Following the release, Wells Fargo maintained an Overweight rating but lowered its price target to $77. This adjustment places the bank's view below the current average analyst target of $84.25, reflecting a more cautious outlook on the stock's valuation.